fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Nitroglycerin

All products: general benefit

Transderm-Nitro · DIN 00852384 · 0.4 mg/Hr/20 Sq Cm · Patch

General benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.Discontinued April 5, 2022 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Transderm-Nitro · DIN 00852384 Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-12-19 Health Canada: Cancelled post market since 2022-04-05 · brand TRANSDERM-NITRO 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Alypsis inc. · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Transderm-Nitro: Formulary list price $1.00 per unit (the source does not state the unit; exact figure $1.0010). What the ministry pays, not the patient.

Ministry pays: $1.0010 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00852384)

Source record
DIN 00852384: Transderm-Nitro Raw flags: sec3=Y Item: 241200034; group id 369; item number 0860; lccId None; manufacturer id NOV Source form: Patch; strength: 0.4mg/Hr/20 Sq Cm Recorded listing: General benefit Source prices (unrounded): $1.0010; ministry $1.0010 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00852384 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10116
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since April 5, 2022 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (C01D, C01DA): coverage varies; not interchangeable

  • Isosorbide dinitrate (Isdn): general benefit, not a benefit
  • Isosorbide + mononitrate (Imdur): not a benefit
  • Vericiguat (Verquvo): limited Use 685
Other drugs in the same formulary class (24:12 Vasodilating Drugs) and how they are covered

Matched class: 24:12 Vasodilating Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): ISOSORBIDE DINITRATE 24:12 Vasodilating Drugs

ISOSORBIDE DINITRATE

· 6 products · General benefit (3), Listed, not a benefit (3) · strengths: 5mg, 10mg, 30mg · SL Tab, Tab

ISOSORBIDE-5-MONONITRATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 60mg · ER Tab

VERICIGUAT

· 3 products · Limited Use, codes 685 · strengths: 2.5mg, 5mg, 10mg · Tab

DIPYRIDAMOLE & ACETYLSALICYLIC ACID

· 2 products · Listed, not a benefit (1), Limited Use, codes 349 (1) · strengths: 200mg/25mg · Cap

NIMODIPINE

· 1 products · Limited Use, codes 42, 43 · strengths: 30mg · Tab

AMBRISENTAN

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 5mg, 10mg · Tab

BETAHISTINE DIHYDROCHLORIDE

· 24 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 8mg, 16mg, 24mg · Tab

BOSENTAN MONOHYDRATE

· 14 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 62.5mg, 125mg · Tab

DIPYRIDAMOLE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 25mg, 50mg, 75mg · Tab

RIOCIGUAT

· 10 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.5mg, 1.5mg, 1mg, 2.5mg, 2mg · Tab

TADALAFIL

· 73 products · Off-Formulary Interchangeable, not an ODB benefit (72), Off-Formulary Interchangeable, not an ODB benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1) · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

VARDENAFIL HCL

· 16 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 10mg, 5mg, 20mg · Orally Disintergrating Tab, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:12
Full class listing Related classes: 24:04 Cardiac Drugs, 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE NITROSTAT (nitroglycerin sublingual tablets) are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. https://pdf.hres.ca/dpd_pm/00070110.PDF PM date: March 27, 2023 Source product: NITROSTAT; DIN 00037613; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.